China SXT Pharmaceuticals Inc. (NASDAQ:SXTC) shares surged 25.6% to $2.11 in after-hours trading on Monday after the company announced a sales agreement with boutique full-service investment bank Univest Securities LLC that enables it to raise up to $100 million through an at-the-market equity offering.
SEC Filing Outlines Flexible Equity Financing
According to a Securities and Exchange Commission filing submitted Monday, China SXT may sell Class A ordinary shares with an aggregate offering value of up to $100 million under the ATM program.
The agreement allows the company to issue shares from time to time on the Nasdaq Capital Market or other permitted trading venues, with Univest Securities acting as sales agent. The firm will receive a 3% commission on gross proceeds, along with reimbursement of certain trading and exchange-related expenses.
What You Should Know
ATM offerings give issuers flexible access to capital, allowing them to raise funds in a way that can adjust to changing market conditions. Instead of selling all shares at once through a single fixed-price offering, shares can be sold gradually over time based on how the market is performing and what conditions are like at each point.
Trading Metrics, Technical Analysis
The China-based innovative pharmaceutical company has a market capitalization of $10.85 million. The stock has traded between a 52-week high of $1,046.98 and a 52-week low of $1.25.
The stock has a Relative Strength Index (RSI) of 39.24.
Over the past 12 months, SXTC has dropped 99.15%.
The small-cap stock is currently trading near its annual low.
The stock’s sharp decline and weak position suggest that selling pressure on the shares may continue. This highlights the high level of risk involved and points to the need for clear and convincing signs of a recovery before investor confidence can improve.
Price Action: According to Benzinga Pro data, the stock closed the regular session at $1.68, up 0.60%.
Benzinga’s Edge Stock Rankings indicate SXTC stock has a negative price trend across all time frames.
Photo courtesy: Gorodenkoff on Shutterstock.com
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Recent Comments